BridgeMD
New treatment option for Rectal Cancer
Official title Artificial Intelligence Assists Surgeons' Decision Making
ClinicalTrials.gov ID: NCT04999007
What this study is testing
- What it's testing
- This study will evaluate whether artificial intelligence technique reduces the temporary ileostomy rate in patients with rectal cancer who receive anterior resection.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Aged older than 18 years and younger than 85 years.
- Primary rectal adenocarcinoma confirmed by preoperative pathology result.
- Expected curative resection via total mesorectal excision procedure.
- American Society of Anesthesiologists (ASA) class I, II, or III.
- Written informed consent.
You likely can't join if
- Pregnant or breastfeeding women.
- Severe mental disorder or language communication disorder.
- Hartmann surgery or colostomy is performed intraoperatively.
- Interrupted of surgery for more than 30 minutes due to any cause.
- Malignant tumors with other organs
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, Hubei, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.